Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jan-Feb;33(1):203-208.
doi: 10.21873/invivo.11460.

Fusion Imaging of Contrast-enhanced Ultrasound With CT or MRI for Kidney Lesions

Affiliations

Fusion Imaging of Contrast-enhanced Ultrasound With CT or MRI for Kidney Lesions

Thomas Auer et al. In Vivo. 2019 Jan-Feb.

Abstract

Aim: To evaluate the feasibility of ultrasound (US) computed tomography (CT) or magnetic resonance imaging (MRI) fusion imaging (FI) for localization and assessment of kidney lesions.

Materials and methods: Twenty-eight patients with kidney lesions previously detected on CT or MRI were included in this retrospective study. All 28 patients with kidney lesions, which were indefinable (42.9%) or hard to localize (57.1%) on gray-scale US alone, underwent FI of US with CT/MRI datasets. In 23 (82%) patients with indeterminate kidney lesions, FI including contrast-enhanced US was conducted.

Results: FI was successfully performed in 25 out of 28 (89.3%) patients. FI with contrast-enhanced US was able to clarify the previously detected kidney lesions in 21 out of 23 patients (91.3%).

Conclusion: FI is a feasible technique for localizing kidney lesions that are hard to define by grayscale US alone and the additional application of contrast-enhanced US is useful in clarifying indeterminate CT or MRI findings.

Keywords: Fusion imaging; computed tomography; contrast-enhanced ultrasound; kidney; magnetic resonance imaging; ultrasound.

PubMed Disclaimer

Figures

Figure 1
Figure 1. This image shows how fusion imaging is able to localize a kidney lesion which was not visible in gray-scale ultrasound (US) alone. After localization with fusion imaging, a solid tumor with contrast enhancement (Bosniak IV) was confirmed by contrast-enhanced US. Partial nephrectomy was performed and the histopathological finding was papillary renal cell cancer. A: In grayscale US, the kidney lesion was isoechoic (arrow) relative to the renal cortex and almost indefinable. B: Synchronized monophasic contrast-enhanced computed tomography showed indeterminate high-attenuation kidney lesion (arrow).
Figure 2
Figure 2. Fusion imaging of contrast-enhanced ultrasound (CEUS) and monophasic contrast-enhanced computed tomography (CT) in a patient with multiple similar kidney lesions (only one lesion is shown). A: Cystic lesion in CEUS with absence of contrast agent uptake on CEUS (arrow). B: High-attenuation (>20 HU) kidney lesion (arrow) on a previously conducted monophasic contrast enhanced CT. After performing fusion imaging with the CT dataset, CEUS excluded contrast enhancement therefore the final diagnosis was Bosniak class II cyst.
Figure 3
Figure 3. Downgrading of a Bosniak class III cyst on magnetic resonance imaging (MRI) to class IIf on contrast-enhanced ultrasound (CEUS). Follow-up confirmed the diagnosis of Bosniak class IIf. A: Image shows fusion imaging with CEUS; note that only septal enhancement (arrow) was visible. B Synchronized previously conducted contrast-enhanced MRI: Bosniak III cyst was diagnosed in MRI because more than septal enhancement was suspected.

Similar articles

Cited by

References

    1. Helenon O, Correas JM, Balleyguier C, Ghouadni M, Cornud F. Ultrasound of renal tumors. Eur Radiol. 2001;11(10):1890–1901. - PubMed
    1. Cokkinos DD, Antypa E, Kalogeropoulos I, Tomais D, Ismailos E, Matsiras I, Benakis S, Piperopoulos PN. Contrast-enhanced ultrasound performed under urgent conditions. Indications, review of the technique, clinical examples and limitations. Insights Imaging. 2013;4(2):185–198. - PMC - PubMed
    1. Helck A, D’Anastasi M, Notohamiprodjo M, Thieme S, Sommer W, Reiser M, Clevert DA. Multimodality imaging using ultrasound image fusion in renal lesions. Clin Hemorheol Microcirc. 2012;50(1-2):79–89. - PubMed
    1. Lee MW, Rhim H, Cha DI, Kim YJ, Choi D, Kim YS, Lim HK. Percutaneous radiofrequency ablation of hepatocellular carcinoma: Fusion imaging guidance for management of lesions with poor conspicuity at conventional sonography. Am J Roentgenol. 2012;198(6):1438–1444. - PubMed
    1. Nakano S, Kousaka J, Fujii K, Yorozuya K, Yoshida M, Mouri Y, Akizuki M, Tetsuka R, Ando T, Fukutomi T, Oshima Y, Kimura J, Ishiguchi T, Arai O. Impact of real-time virtual sonography, a coordinated sonography and MRI system that uses an image fusion technique, on the sonographic evaluation of MRI-detected lesions of the breast in second-look sonography. Breast Cancer Res Treat. 2012;134(3):1179–1188. - PubMed